Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Published on by Shen Awards

Dr. Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Manipal College of Pharmaceutical Sciences, MAHE, Manipal, India

Dr. Gollapalle L. Viswanatha is a distinguished pharmacologist and toxicologist with over 17 years of expertise in pharmaceutical R&D, regulatory toxicology, and preclinical research. Currently serving as a Manager at ClinChoice Pvt. Ltd., Bengaluru, he has held pivotal roles in organizations like IQVIA, The Himalaya Drug Company, and Connexios Life Sciences. A prolific academic and industry contributor, Dr. Viswanatha has authored over 100 peer-reviewed articles and delivered more than 20 expert talks in global forums. As a DABT-certified and European Registered Toxicologist (ERT), his work bridges cutting-edge science with regulatory excellence. He also serves as adjunct faculty at Manipal College of Pharmaceutical Sciences, mentoring postgraduate students and contributing to academic research. His pioneering efforts in herbal drug evaluation, regulatory documentation, and systematic reviews make him a leading voice in toxicology and pharmacology. With several novel animal models to his credit, he actively influences drug discovery and translational medicine.

Professional Profile

Educational 

Dr. Viswanatha holds a PhD in Pharmaceutical Sciences (2019) from JNTU Anantapur, with a dissertation focused on indigenous medicinal plants against stroke and epilepsy. He is board-certified by the American Board of Toxicology (DABT, 2023) and recognized as a European Registered Toxicologist (ERT, 2022). He completed a PG Diploma in Statistical Quality Control and earned a Six Sigma Green Belt from the Indian Statistical Institute (ISI), Bengaluru in 2017, both with Grade ‘A’. He holds an M. Pharm in Pharmacology (2008) from RGUHS, Bengaluru, graduating with 77% and was honored as the Best Outgoing Student. Additionally, he is a GATE and GPAT qualifier. His academic foundation is marked by a multidisciplinary understanding of pharmacology, quality systems, and toxicology. Throughout his academic journey, he has demonstrated a commitment to both practical research and methodological rigor, blending statistical competence with clinical relevance in drug discovery and safety sciences.

Professional Experience

Dr. Viswanatha has a robust professional background spanning regulatory toxicology, preclinical pharmacology, and data surveillance. Currently, he leads the toxicology division at ClinChoice Pvt. Ltd. (2021–present), overseeing cosmetic ingredient safety, CTD preparation, biocompatibility risk assessments, and toxicological risk evaluations. He formerly worked at IQVIA India Pvt. Ltd. (2014–2021) as a Senior Medical Data Reviewer, specializing in clinical trial surveillance and protocol compliance for myocardial infarction studies. Prior to that, he served as a Research Associate at The Himalaya Drug Company (2010–2014), standardizing herbal drug models, and as a Scientist at Connexios Life Sciences (2008–2010), handling PK, safety pharmacology, and toxicological assessments of NCEs. His interdisciplinary approach combines GLP compliance, regulatory documentation, safety evaluations, and project leadership. With broad expertise across pharmaceuticals, nutraceuticals, and cosmetics, he has contributed to product development from discovery to regulatory submission while mentoring cross-functional teams and managing end-to-end project execution.

Awards and Honors 

Dr. Viswanatha has received numerous accolades throughout his academic and professional journey. He was honored with the prestigious Joe-Mae International Young Scientist Award by the AMS Society in Hong Kong (2016) and was a nominee for the Dr. Achari Award at IPSCON 2012 for his work on a novel pharyngitis animal model. He earned the title of Best Outgoing Student during his M. Pharm (2006–2008) and successfully qualified in GATE 2007, GPAT 2010 & 2011. His innovative contributions include the development of novel animal models for non-infectious pharyngitis and hemorrhoids. He has been invited for over 10 expert talks, delivered 5 hands-on workshops, and reviewed articles for over 35 high-impact journals, reflecting his standing as a respected thought leader. These honors underscore his commitment to translational pharmacology, scientific innovation, and academic mentorship, bridging traditional medicine with modern pharmacological practices.

Research Interests 

Dr. Viswanatha’s research interests span preclinical pharmacology, regulatory toxicology, herbal medicine, and evidence-based drug evaluation. His work focuses on stroke, epilepsy, neurodegeneration, nephroprotection, pharyngitis, and gastrointestinal and cardiovascular pharmacology, often using rodent models. He has a strong inclination toward toxicological risk assessment (TRA), biocompatibility studies, and regulatory documentation for pharmaceuticals and cosmetics. His current pursuits involve systematic reviews and meta-analyses on both clinical and preclinical data, particularly emphasizing GABAergic modulation, anti-inflammatory agents, and flavonoids like naringin. He also contributes to safety pharmacology and real-world evidence generation. Beyond therapeutic investigations, he’s deeply involved in OECD-compliant toxicology, SCCS cosmetic safety dossiers, and ISO 10993-based device safety evaluations. His dual strength in bench science and regulatory frameworks makes his research both impactful and implementation-ready, aligning traditional pharmacological principles with global safety standards.

Research Skills

Dr. Viswanatha possesses advanced skills in in vivo and in vitro pharmacological/toxicological experimentation, including GLP-compliant animal models using rats, mice, rabbits, and guinea pigs. He is proficient in conducting acute, repeated dose, and genotoxicity studies, and safety pharmacology evaluations per ICH guidelines. He excels in meta-analysis and systematic reviews using RevMan, RoB-2, G-Power, and Newcastle-Ottawa scales, alongside regulatory documentation (CTD modules 2.4 & 2.6, CPSR, ADE/PDE/OEL assessments). He has expertise in SCCS guidelines, QSAR & AOT software tools, and data analysis using GraphPad Prism, SPSS, and Minitab. He’s also skilled in toxicological literature mining using PubMed, ECHA, PubChem, and other databases. A Six Sigma Green Belt and SQC professional, his approach blends quality systems with analytical rigor. His research strengths lie in project management, protocol development, real-world evidence integration, and regulatory toxicology strategy, making him an asset across life sciences domains.

Conclusion

Dr. Viswanatha exemplifies a rare blend of rigorous experimental pharmacology and robust regulatory toxicology. His multidisciplinary education and certifications, from PhD to international toxicology credentials, underpin his leadership in both academic and industry domains. With a strong track record in innovative animal model development, systematic reviews, and regulatory documentation, he drives preclinical-to-clinical translation effectively. His prolific publication record, awards, and advisory roles highlight a distinguished career that continues to influence global life sciences.

 Publication Top Notes

  • 🧠 Clinical study on cisplatin‑induced nephrotoxicity in humans – PA Arunkumar et al. (2012)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn: A review – D Manohar et al. (2012)

  • 🍃 Antioxidant & anti-inflammatory activity of Mangifera indica leaf extracts – CG Mohan et al. (2013)

  • 🍊 Naringin’s neuroprotective neurobehavioral review/meta-analysis – GL Viswanatha et al. (2017)

  • 🍎 Isolation of antidiabetic principle from Punica granatum rinds – V Jain et al. (2012)

  • 🌳 POG‑glucose inhibits 11β‑HSD‑1 & ameliorates diet-induced diabetes – CG Mohan et al. (2013)

  • 🍋 Lemongrass oil for dexamethasone-induced hyperlipidemia – VRS Kumar et al. (2011)

  • 💊 Hepatoprotective activity of Hepax polyherbal formulation – VC Devaraj et al. (2011)

  • 🌿 Antioxidant & antimutagenic activities of Terminalia arjuna bark – GL Viswanatha et al. (2013)

  • 🩸 Rat model of hemorrhoids: anti‑hemorrhoidal study – M Azeemuddin et al. (2014)

  • 💧 LC‑MS/MS quantification of flavonoids in Moringa & Raphinus – VC Devaraj et al. (2011)

  • 🧠 Animal models of chemotherapy‑induced cognitive decline – J John et al. (2021)

  • 💡 Bacopa monnieri + rivastigmine memory reversal in rats – AHM Thippeswamy et al. (2016)

  • 🍊 Hesperidin’s neuroprotective & mitochondrial benefits – GL Viswanatha et al. (2012)

  • ⚡ Anti‑epileptic activity of Punica granatum leaf extracts – GL Viswanatha et al. (2016)

  • 🌲 Anxiolytic & anticonvulsant activity of Cedrus deodara – GL Viswanatha et al. (2009)

  • 🧠 POG‑glucose alleviates ischemia/reperfusion brain injury – GL Viswanatha et al. (2013)

  • 🧪 Anti‑ulcer effect of Raphinus sativus leaves – VC Devaraj et al. (2011)

  • 🌱 Gymnema sylvestre extract improves glucose uptake – PM Kumar et al. (2016)

  • 🍇 Phytochemical standardization of Punica granatum – V Jain et al. (2011)

  • 🌸 Anti‑fertility activity of Tabernaemontana divaricata flowers – MA Mukhram et al. (2012)

  • 🧊 Anti‑urolithiatic effect of Cedrus deodara extract – N Krishnadas et al. (2010)

  • 💩 Antidiarrheal activity of Thespesia populnea bark fractions – GL Viswanatha et al. (2011)

  • 🦴 Anti‑osteoporotic effect of herbal formula NR/CAL/06 – P Srikanta et al. (2011)

  • 🌿 Antidiarrheal activity of Lepidium sativum seed extract – D Manohar et al. (2011)

  • 🧠 Acteoside from Colebrookea – anti‑epileptic effects – GL Viswanatha et al. (2016)

  • 💊 Thienotriazines: synthesis & antihistaminic activity – GL Viswanatha et al. (2012)

  • 🧠 Punica granatum extract protects against I/R brain injury – GL Viswanatha et al. (2014)

  • 🌱 Colebrookea oppositifolia root for stroke – cerebroprotective effect – GL Viswanatha et al. (2019)

  • 💥 Anticonvulsant activity of POG‑glucose from Mangifera indica – GL Viswanatha et al. (2018)

  • 💊 Mechanisms of biochanin‑A: a pharmacological review – PV Anuranjana et al. (2010)

  • 🧬 Diabetic wound healing: update – R Keni et al. (2012)

  • 🛡️ Cardioprotective preclinical systematic review on naringin – GL Viswanatha et al. (2023)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn. review – M Divanji et al. (2022)

  • 🧠 Erythrina variegata bark extract: anxiolytic & anticonvulsant – G Pitchaiah et al. (2023)

 

Phuong Linh Ta | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Ms. Phuong Linh Ta | Pharmaceutical Science | Best Researcher Award

University CEU CArdenal Herrera, Spain

Phuong Linh Ta is an emerging researcher in the field of pharmacology, currently pursuing her doctoral studies at Universidad Cardenal Herrera CEU in Spain. She is a highly motivated scientist with a solid academic foundation and practical experience in pharmaceutical research, particularly focusing on ocular drug delivery systems and antibiotic discovery. Throughout her career, she has actively contributed to impactful projects that address pressing global health concerns, such as the development of new antibiotics and the prevention of cognitive decline associated with diseases like Alzheimer’s. She has consistently demonstrated a passion for contributing to both scientific advancement and community well-being through her involvement in various outreach programs including elderly care and sustainable development challenges. Phuong Linh Ta’s scientific journey is marked by a balanced integration of academic excellence, innovative research, and social engagement. Her participation in prestigious conferences across Europe has allowed her to present her work to the international scientific community, thereby expanding her professional network and research visibility. With her commitment to continuous learning, interdisciplinary collaboration, and practical applications in the pharmaceutical field, Phuong Linh Ta is steadily building a robust research portfolio that holds promise for future breakthroughs in pharmacology and clinical applications.

Professional Profile

Education

Phuong Linh Ta’s educational background showcases a steady progression in pharmaceutical sciences and clinical research. She completed her Master’s degree in Direction and Monitorization of Clinical Trials from Universidad Cardenal Herrera CEU in 2022, equipping her with specialized knowledge in clinical trial design and pharmaceutical study management. Prior to that, she earned her Bachelor’s degree in Pharmacy from the same university in 2021, which provided her with a strong foundation in pharmacological principles, drug formulation, and patient care. She also participated in the Forster Summer School at the University of Mainz in 2019, where she gained international exposure and broadened her academic perspective. Her early academic journey includes completing the International Baccalaureate at Birkerød Gymnasium, HF, IB & Boarding School in Denmark, which highlights her global educational experience. This diverse and international academic pathway has given her a broad cultural and scientific outlook, enhancing her adaptability and communication across different educational and professional environments. Her formal education has been consistently aligned with her research interests, particularly in clinical pharmacology, drug delivery systems, and public health, positioning her well for her doctoral research and future contributions to the pharmaceutical sector.

Professional Experience

Phuong Linh Ta has developed substantial professional experience through various academic roles at Universidad Cardenal Herrera CEU. She is currently engaged as a doctoral student in the Faculty of Pharmacy, focusing on pharmacology research, with her work beginning in November 2022. Her previous roles include serving as a Pharmacy Classroom Assistant, where she provided educational support and facilitated learning for undergraduate students. Additionally, she worked as an Internal Student in the Department of Pharmacology, where she honed her laboratory and research skills through hands-on involvement in pharmaceutical studies. Her collaborative roles in the departments of Languages and Communication further enriched her interpersonal, administrative, and organizational capabilities, demonstrating her versatility and commitment to contributing to different facets of the university environment. These experiences have provided her with a well-rounded understanding of both research and academic operations, preparing her for independent and collaborative work in complex scientific projects. Her sustained professional engagement within the same institution illustrates her reliability, long-term dedication, and growth within the academic community. Her evolving responsibilities have enabled her to build a solid foundation in both teaching and research, setting the stage for her continued contributions to the field of pharmacology.

Research Interest

Phuong Linh Ta’s primary research interests lie at the intersection of pharmacology, drug delivery systems, and clinical applications aimed at improving patient outcomes. She is particularly focused on the development of ocular drug delivery platforms, including the formulation and characterization of ocular inserts to enhance the bioavailability and targeted release of therapeutic agents. Her recent research has concentrated on using alpha-lipoic acid in beta-cyclodextrin complexes for improved delivery to the posterior segment of the eye, which holds significant potential for the treatment of ocular diseases and the prevention of long-term complications associated with high myopia. Additionally, she has been involved in projects that address global health challenges such as the discovery of new antibiotics and the promotion of their rational use, aligning her work with the global fight against antimicrobial resistance. Her interest extends to neuroprotective strategies for the early prevention of cognitive deterioration, reflecting her multidisciplinary approach that bridges pharmaceutical technology with public health priorities. Phuong Linh Ta’s research is deeply rooted in translating laboratory findings into practical healthcare solutions, and she is committed to advancing drug delivery science to make therapeutics more efficient, accessible, and patient-centered.

Research Skills

Phuong Linh Ta possesses a diverse range of research skills that are crucial to her contributions in pharmaceutical sciences. She is proficient in developing and characterizing drug delivery systems, particularly ocular inserts, and has significant experience in in vitro release studies and ex vivo diffusion studies. Her technical expertise includes working with complex molecular assemblies like beta-cyclodextrin complexes, optimizing drug stability and bioavailability. She is skilled in conducting clinical trials, managing pharmacological experiments, and applying service-learning methodologies in educational and research settings. Her involvement in competitive R&D projects has also equipped her with skills in project planning, data analysis, and scientific reporting. Furthermore, she has effectively communicated her research findings at multiple international conferences, indicating her capability in scientific presentation and knowledge dissemination. Phuong Linh Ta’s multilingual abilities—fluency in Vietnamese, Spanish, and English—further enhance her collaborative potential in diverse research environments. Her capacity to integrate laboratory research with clinical applications and her aptitude for both independent and team-based work make her a versatile and competent researcher. She continuously seeks to refine her laboratory techniques, analytical skills, and knowledge of pharmacological systems to remain at the forefront of her field.

Awards and Honors

As of the current stage of her career, Phuong Linh Ta’s recognition is primarily reflected in her selection for multiple competitive research projects and her invitations to present at prestigious scientific conferences across Europe. She has actively participated in national and international conferences such as EVER, the Controlled Release Society (CRS) Annual Meeting, and the Spanish-Portuguese Conference on Controlled Drug Delivery. These platforms have provided her with opportunities to showcase her research and gain valuable feedback from global experts. Her consistent involvement in the SWI@CEU project and the DeCo MICOF-CEU project demonstrates the trust her academic institution places in her research capabilities. While she has not yet accumulated formal awards or fellowships, her current academic track record and research engagement highlight her potential for future recognition and academic distinction. Participation in such competitive and high-impact research initiatives serves as an important professional milestone, indicating her emerging status within the scientific community. Moving forward, continued success in publishing peer-reviewed articles and leading independent research projects will likely pave the way for her to receive more significant awards, grants, and honors that will further validate her contributions to pharmaceutical sciences.

Conclusion

Phuong Linh Ta is a dedicated and promising researcher who has steadily built a strong foundation in pharmacology and pharmaceutical research through her education, professional experience, and focused scientific contributions. Her work reflects a commitment to developing innovative drug delivery systems, with particular emphasis on ocular therapeutics and public health impact. While her research is still in the early stages, she has already gained substantial international exposure and actively contributed to community-based and service-learning projects. Her technical skills, multilingual proficiency, and ability to collaborate in multidisciplinary teams make her well-prepared to take on more advanced research challenges in the future. Although there are areas for growth, especially in peer-reviewed publications and leadership of independent projects, her trajectory suggests she is on the right path toward becoming a highly impactful researcher. With further development and continued dedication, Phuong Linh Ta has the potential to significantly contribute to advancements in drug delivery, pharmacology, and patient-centered healthcare solutions. Her work is aligned with global health priorities, and she is well-positioned to make meaningful scientific contributions in both academic and clinical contexts.

Publications Top Notes

  • Title: Optimization and Validation of a High‐Performance Liquid Chromatography (HPLC‐UV) Method for Quantification of α‐Lipoic Acid in Cyclodextrins Complex for Ocular Delivery

  • Authors: Phuong Linh Ta, Lucia Bernat‐Just, Adrián M. Alambiaga‐Caravaca, Vicent Rodilla, Alicia López‐Castellano, Francisco Bosch‐Morell

  • Year: 2025

Hafiz Hussain | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Hafiz Hussain | Pharmaceutical Science | Best Researcher Award

Assistant Professor at Cholistan University of Veterinary and Animal Sciences Bahawalpur, Pakistan

Dr. Hafiz Iftikhar Hussain is an esteemed Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur, Pakistan. With a strong background in veterinary pathology, he has made significant contributions to research and academia. His expertise lies in bacterial and viral disease pathology in poultry and livestock, with a focus on antibiotic resistance and molecular diagnostics. Dr. Hussain has extensive experience in research methodologies, including whole-genome sequencing, transcriptomic profiling, and biofilm detection. As a dedicated academician, he also serves as Coordinator for undergraduate programs and Additional Director of Student Affairs at CUVAS. He is an active member of several professional associations, including the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His commitment to scientific excellence is evident through his numerous publications, conference presentations, and roles as a reviewer for prestigious journals. Dr. Hussain’s passion for advancing veterinary sciences, particularly in pathology and disease control, underscores his professional journey. His remarkable achievements, including scholarships, best paper awards, and active participation in national and international conferences, reflect his dedication to research, education, and the betterment of animal health sciences in Pakistan and beyond.

Professional Profile

Education

Dr. Hafiz Iftikhar Hussain has an impressive academic background in veterinary sciences and pathology. He earned his Doctor of Philosophy (PhD) in Basic Veterinary Medicine, specializing in Pathobiology, from Huazhong Agricultural University, China, in 2017, with an outstanding score of 81.75%. Prior to his PhD, he completed a Master of Philosophy (M.Phil) in Pathology from the University of Agriculture, Faisalabad, in 2012, focusing on histopathology and toxicology with a commendable CGPA of 3.81/4.00. His foundational education includes a Doctor of Veterinary Medicine (DVM) degree from the University of Agriculture, Faisalabad, completed in 2010, with a CGPA of 3.26/4.00. Dr. Hussain began his academic journey with a Higher Secondary School Certification (F.Sc. Pre-Medical) from the Federal Board of Intermediate and Secondary Education, Islamabad, securing 74% marks in 2005. His early education was completed with a Secondary School Certification in Science from the Board of Intermediate and Secondary Education, Sargodha, where he achieved an excellent 85.77% in 2003. His strong educational foundation has equipped him with advanced knowledge in veterinary pathology, toxicology, and molecular diagnostics, laying the groundwork for his research and academic pursuits in veterinary sciences.

Professional Experience

Dr. Hafiz Iftikhar Hussain has amassed extensive professional experience in veterinary pathology and academia. His career began as a self-employed veterinary doctor at Al-Shifa Veterinary Clinic and Lab in Farooka, Sargodha, from August 2012 to August 2013. He then transitioned to academia as an Assistant Professor in the Department of Veterinary Pathology at PMAS-Arid Agriculture University, Rawalpindi, where he served from July to December 2018. Since December 2018, Dr. Hussain has been an Assistant Professor in the Department of Pathology at Cholistan University of Veterinary and Animal Sciences (CUVAS), Bahawalpur. Alongside his teaching responsibilities, he plays a crucial administrative role as the Coordinator for BS Doctor of Veterinary Medicine (DVM) and BS Medical Laboratory Technology programs. Additionally, he serves as the Additional Director of Student Affairs at CUVAS, demonstrating his leadership and commitment to academic excellence. Dr. Hussain is an active member of professional organizations such as the Pakistan Veterinary Medical Council and the Pakistan Biological Safety Association. His experience spans both clinical practice and academia, making him a distinguished figure in veterinary pathology and a mentor for aspiring veterinarians in Pakistan.

Research Interests

Dr. Hafiz Iftikhar Hussain’s research interests lie at the intersection of veterinary pathology, microbiology, and molecular diagnostics. His primary focus is on antibiotic resistance mechanisms, bacterial pathogenesis, and molecular characterization of multidrug-resistant pathogens, particularly Escherichia coli in poultry. He has conducted extensive research on extended-spectrum beta-lactamase (ESBL) detection and whole-genome sequencing to understand resistance genes in bacterial populations. His studies also explore the pathogenesis of viral and bacterial diseases in poultry and livestock, with an emphasis on biofilm formation and detection. Additionally, Dr. Hussain has a keen interest in transcriptomic profiling, protein extraction, and the development of animal models to study disease mechanisms. His research contributes to the global fight against antimicrobial resistance, aiming to develop strategies for better disease control and prevention in veterinary medicine. As an advocate for One Health, he also investigates zoonotic disease transmission and its implications for public health. His work has been widely recognized, earning him numerous publications in high-impact journals and invitations to present at international conferences. Through his research, Dr. Hussain strives to enhance disease diagnosis, treatment, and control strategies to improve animal and human health.

Research Skills

Dr. Hafiz Iftikhar Hussain possesses a comprehensive skill set in veterinary pathology and molecular diagnostics. His expertise includes antibiotic resistance determination, extended-spectrum beta-lactamase (ESBL) detection, and whole-genome re-sequencing. He is proficient in high-performance liquid chromatography (HPLC), polymerase chain reaction (PCR), and DNA, RNA, and protein extraction techniques. His research capabilities extend to RNA sequencing, biofilm formation studies, enzyme-linked immunosorbent assay (ELISA), and spectrophotometry. Dr. Hussain is also experienced in developing cell lines and utilizing animal modeling for disease studies. In addition to his laboratory skills, he is well-versed in various bioinformatics tools, enabling him to analyze complex genomic data efficiently. His proficiency in Microsoft Office, Adobe Photoshop for scientific presentations, and statistical analysis software further supports his research endeavors. Dr. Hussain’s technical expertise has been instrumental in advancing his research on antimicrobial resistance, bacterial pathogenesis, and disease diagnostics. His ability to integrate traditional pathology techniques with modern molecular approaches makes him a valuable contributor to veterinary sciences. With a strong commitment to continuous learning and innovation, he remains at the forefront of veterinary research, working to enhance disease control strategies in animal health.

Awards and Honors

Dr. Hafiz Iftikhar Hussain has received numerous accolades for his academic and research contributions. He was awarded a scholarship from the Chinese Scholarship Council for his PhD studies at Huazhong Agricultural University. Throughout his education, he was a consistent scholarship holder from grade six to his PhD. In recognition of his outstanding research, he won the ‘Best Student Paper Award’ at the First Annual Academic Symposium for International Students in 2018 at Huazhong Agricultural University. His academic achievements include earning the esteemed Sahadat-e-Hifz-ul-Quran certification from Wafaq-ul-Madaris, Islamabad. As a recognized expert, Dr. Hussain is a certified reviewer for the ‘Antimicrobial Resistance & Infection Control’ journal and serves as a reviewer for high-impact journals, including Frontiers in Veterinary Science and PLOS ONE. His dedication to veterinary sciences and research has positioned him as a leader in his field, making significant contributions to veterinary pathology and microbiology. These honors reflect his unwavering commitment to excellence, research innovation, and the advancement of animal health sciences at both national and international levels.

Conclusion

Dr. Hafiz Iftikhar Hussain stands as a distinguished figure in veterinary pathology, academia, and research. His extensive expertise in bacterial and viral disease pathology, antimicrobial resistance, and molecular diagnostics has significantly contributed to veterinary sciences. With a strong academic background, he has successfully combined clinical practice, teaching, and research to mentor future veterinarians. His role as an Assistant Professor, program coordinator, and student affairs director at CUVAS demonstrates his leadership and dedication to education. Through his research, he has made remarkable advancements in understanding antibiotic resistance and bacterial pathogenesis, earning prestigious awards and international recognition. His technical skills in genomics, pathology, and bioinformatics further enhance his contributions to disease control and prevention. As an active member of professional organizations and a reviewer for high-impact journals, Dr. Hussain continues to influence the field of veterinary medicine. His commitment to scientific excellence and student mentorship underscores his vision for a healthier future in veterinary and public health. His work remains instrumental in shaping the next generation of veterinary professionals and improving animal health through innovative research and education.

Publications Top Notes

  1. “Optimization and production of highly stable amylase isolated from Citrobacter portucalensis using low-cost agro-industrial wastes as substrates: Prospective therapeutics”

    • Authors: Ume E. Salma Liaqat, Shumaila Naz, Hafiz Iftikhar Hussain
    • Year: 2024
    • Journal: Kuwait Journal of Science

  2. “Phytochemical Screening, Anti-Inflammatory, and Antidiabetic Activities of Different Extracts from Caralluma edulis Plant”

    • Authors: Maria Khan, Zahid Manzoor, Muhammad Q. Rafiq, Katarzyna Kotwica-Mojzych, Mariusz Mojzych
    • Year: 2022
    • Journal: Molecules
    • Citations: 9